Share
    NEW SEARCH RETURN TO SEARCH RESULTS
Number: 201307077 Principal Investigator: Waqar, Saiama
Title: A Multi-Center, Open-Label, Randomized Phase II Study to Evaluate the Efficacy of AUY922 vs. pemetrexed or docetaxel in NSCLC Patients with EGFR Mutations who have Progressed on prior EGFR TKI Treatment
Phase: II Disease Site: Lung
Participating Site(s):
 
Main Campus
Map and Directions
South County
Map and Directions
St. Peters
Map and Directions
West County
Map and Directions
 
Contact: 800-600-3606 or info@ccadmin.wustl.edu

Description:
The purpose of this study is to find out whetehr AUY922, Pemetrexed, or Docetaxel is best able to stop lung cancer from spreading and growing.
 
More Information:
ClinicalTrials.Gov
Internal Protocol Documents (requires Siteman administrative database password)